Premium
Reversible Pisa syndrome (pleurothotonus) due to the cholinesterase inhibitor galantamine: Case report
Author(s) -
Cossu Giovanni,
Melis Maurizio,
Melis Giannina,
Maccioni Elisabetta,
Putzu Valeria,
Catte Olga,
Putzu Paolo Francesco
Publication year - 2004
Publication title -
movement disorders
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.352
H-Index - 198
eISSN - 1531-8257
pISSN - 0885-3185
DOI - 10.1002/mds.20164
Subject(s) - galantamine , cholinesterase , botulinum toxin , medicine , degenerative disease , neurological disorder , disease , psychology , central nervous system disease , donepezil , anesthesia , pharmacology , dementia
We report on a case of reversible Pisa syndrome developed after treatment with galantamine in a patient with Alzheimer's disease without previous exposure to neuroleptic or other cholinesterase inhibitors. Complete and persistent resolution of the syndrome was achieved several weeks after botulinum toxin type‐A injection. © 2004 Movement Disorder Society